Patients with diabetes are at higher risk for severe illness from COVID-19-Reference-Cited by-同舟云学术

Patients with diabetes are at higher risk for severe illness from COVID-19

Published:2020-09 Issue:4 Volume:46 Page:335-337
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Targher G.^ORCID,Mantovani A.^ORCID,Wang X.-B.,Yan H.-D.,Sun Q.-F.,Pan K.-H.,Byrne C.D.,Zheng K.I.^ORCID,Chen Y.-P.,Eslam M.,George J.,Zheng M.-H.^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference7 articles.

1. WHO characterises COVID-19 as a pandemic;WHO.,2020

2. The diabetes pandemic and associated infections: suggestions for clinical microbiology;Toniolo;Rev Med Microbiol,2019

3. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression;Huang;Diabetes Metab Syndr,2020

4. Diagnosis and treatment protocol for novel Coronavirus pneumonia (trial version 7);National Health Commission and State Administration of Traditional Chinese Medicine,2020

5. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes;Zhu;Cell Metab,2020

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial;European Journal of Heart Failure;2023-10-09

2. Intervention Effects of Physical Activity on Type 2 Diabetic Patients Potentially Infected with COVID-19;Medicina;2023-10-05

3. Effects of novel glucose-lowering drugs on the COVID-19 patients with diabetes: A network meta-analysis of clinical outcomes;International Journal of Diabetes in Developing Countries;2023-08-08

4. Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study;Diabetes, Metabolic Syndrome and Obesity;2023-08

5. The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin;Biomedicine & Pharmacotherapy;2023-07